Optimind Pharma Corp. (CSE:OMND)

Market Cap	515.74K
Revenue (ttm)	131.48K +18.1%
Net Income	-66.45K
EPS	-0.00
Shares Out	103.15M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,000
Average Volume	18,580
Open	0.0050
Previous Close	0.0100
Day's Range	0.0050 - 0.0050
52-Week Range	0.0050 - 0.0100
Beta	0.16
RSI	45.97
Earnings Date	Jan 29, 2026

About Optimind Pharma

Optimind Pharma Corp. provides psychedelic therapies in Canada. The company offers psychedelic-like therapies for the treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities through ketamine-assisted treatment and other psychedelic enhanced psychotherapy modalities. It also prescribes medical cannabis and other alternative treatments for various medical ailments through its clinics. Optimind Pharma Corp. is headquartered in Toronto, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: David Goodman
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: OMND

Financial Performance

In fiscal year 2025, Optimind Pharma's revenue was 118,368, a decrease of -3.73% compared to the previous year's 122,959. Losses were -215,812, -84.56% less than in 2024.